High Pointe Capital Management’s Boston Scientific BSX Stock Holding History

High Pointe Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-38,620	Closed	-$1.57M	–	81
2019 Q3	$1.57M	Buy	38,620 +990	+3%	+$41.9K	2.15%	13
2019 Q2	$1.62M	Hold	37,630	–	–	2.27%	11
2019 Q1	$1.44M	Sell	37,630 -7,830	-17%	-$299K	1.98%	11
2018 Q4	$1.61M	Sell	45,460 -250	-0.5%	-$9.07K	2.64%	8
2018 Q3	$1.76M	Hold	45,710	–	–	2.37%	9
2018 Q2	$1.5M	Hold	45,710	–	–	2.13%	14
2018 Q1	$1.25M	Buy	45,710 +26,280	+135%	+$714K	1.72%	20
2017 Q4	$482K	Hold	19,430	–	–	0.66%	56
2017 Q3	$567K	Sell	19,430 -690	-3%	-$19.1K	0.83%	48
2017 Q2	$558K	Sell	20,120 -6,940	-26%	-$184K	0.87%	45
2017 Q1	$673K	Sell	27,060 -870	-3%	-$21.2K	1.06%	41
2016 Q4	$604K	Hold	27,930	–	–	0.99%	47
2016 Q3	$665K	Hold	27,930	–	–	1.18%	37
2016 Q2	$653K	Sell	27,930 -55,800	-67%	-$1.21M	1%	43
2016 Q1	$1.57M	Sell	83,730 -102,690	-55%	-$1.8M	2.28%	15
2015 Q4	$3.44M	Buy	186,420 +48,460	+35%	+$868K	1.69%	9
2015 Q3	$2.26M	Buy	+137,960	New	+$2.36M	1.06%	20

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

High Pointe Capital Management's BSX Position: Q4 2019 in Review

High Pointe Capital Management sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 38,620 shares — an estimated $1.57M sold.

High Pointe Capital Management first reported a position in BSX in Q3 2015 and held it in 17 quarters. The position peaked at $3.44M in Q4 2015. 854 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

High Pointe Capital Management reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
High Pointe Capital Management sold 38,620 Boston Scientific shares in Q4 2019, an estimated $1.57M.
High Pointe Capital Management first reported a position in Boston Scientific in Q3 2015 and held it in 17 quarters.
High Pointe Capital Management's Boston Scientific position peaked at $3.44M in Q4 2015.
854 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on High Pointe Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.